Literature DB >> 12411468

Role of cyclooxygenase-2 in the prolonged regulation of renal function.

Francisco Roig1, Maria T Llinás, Ruth López, F Javier Salazar.   

Abstract

The role of cyclooxygenase-2 (COX-2) in the prolonged regulation of renal function was evaluated during changes in sodium intake and reduction of NO synthesis. It was evaluated in conscious dogs by administering a selective inhibitor (nimesulide) during 8 consecutive days. Nimesulide administration to dogs with normal or high sodium load did not modify glomerular filtration rate but reduced renal blood flow (16%; P<0.05). The vasoconstriction elicited by COX-2 inhibition was greater when NO production was inhibited because glomerular filtration rate decreased by >25% when nimesulide was administered to dogs with a reduced NO synthesis. During low sodium intake, COX-2 inhibition elicited a decrease (P<0.05) of both glomerular filtration rate (34%) and renal blood flow (31%). Sodium excretion only decreased (P<0.05) during the first day of COX-2 inhibition in dogs with normal or high sodium load. The increase in plasma potassium levels elicited by COX-2 inhibition was greater in dogs with low sodium intake and was enhanced when NO production was inhibited. This change in potassium was not secondary to a decrease in plasma aldosterone levels. The results of this study suggest that COX-2-derived metabolites (1) play a more important role in the long-term regulation of renal hemodynamic when sodium intake is low, (2) protect the renal vasculature from the vasoconstriction secondary to a reduction in NO, (3) are only acutely involved in regulating urinary sodium excretion, and (4) play a more important role in regulating plasma potassium concentration when NO synthesis is reduced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411468     DOI: 10.1161/01.hyp.0000036451.76323.29

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  [Non-opioid analgesics for perioperative pain therapy. Risks and rational basis for use].

Authors:  A Brack; H L Rittner; M Schäfer
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

2.  Renal medullary cyclooxygenase-2 and (pro)renin receptor expression during angiotensin II-dependent hypertension.

Authors:  Alexis A Gonzalez; Torrance Green; Christina Luffman; Camille R T Bourgeois; L Gabriel Navar; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

3.  Upregulation of cyclooxygenase-2 expression in porcine macula densa with chronic nitric oxide synthase inhibition.

Authors:  M Kommareddy; R M McAllister; V K Ganjam; J R Turk; M Harold Laughlin
Journal:  Vet Pathol       Date:  2010-12-15       Impact factor: 2.221

Review 4.  The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function.

Authors:  Torrance Green; Alexis A Gonzalez; Kenneth D Mitchell; L Gabriel Navar
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

5.  Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II.

Authors:  Torrance Green; Jorge Rodriguez; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-28

Review 6.  Interaction of the renin angiotensin and cox systems in the kidney.

Authors:  Syed S Quadri; Silas A Culver; Caixia Li; Helmy M Siragy
Journal:  Front Biosci (Schol Ed)       Date:  2016-06-01

Review 7.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

8.  Effects of selective Cox-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal Cox-2 expression in rats.

Authors:  Fatih Kose; Ayberk Besen; Saime Paydas; Mustafa Balal; Gulfiliz Gonlusen; Tamer Inal; Ayse Dogan; Mustafa Kibar
Journal:  Clin Exp Nephrol       Date:  2009-10-01       Impact factor: 2.801

Review 9.  Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?

Authors:  Shanzana Khan; Karen L Andrews; Jaye P F Chin-Dusting
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.